Adial Pharmaceuticals, Inc. (ADIL)
USD 1.11
(-1.77%)
USD 1.11
(-1.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 564.00 | 60.5 Thousand | 55.1 Thousand | 564.00 | 565.00 | 563.00 |
| Gross Profit | -564.00 | -60.5 Thousand | -55.1 Thousand | -564.00 | -565.00 | -563.00 |
| Operating Expenses | 6.88 Million | 13.31 Million | 17.74 Million | 10.92 Million | 8.24 Million | 6.98 Million |
| Selling, General and Administrative Expenses | 5.62 Million | 9.14 Million | 9.34 Million | 5.07 Million | 4.27 Million | 6.61 Million |
| Research and Development Expenses | 1.26 Million | 4.17 Million | 8.39 Million | 5.85 Million | 3.96 Million | 368.45 Thousand |
| Other Expenses | - | - | 46.49 Thousand | 2500.00 | - | - |
| Cost and Expenses | 6.88 Million | 13.31 Million | 17.74 Million | 10.92 Million | 8.24 Million | 6.98 Million |
| Operating Income | -6.88 Million | -13.31 Million | -19.28 Million | -10.92 Million | -8.24 Million | -6.98 Million |
| Interest Expense | - | - | - | - | - | 1.16 Million |
| Income Tax Expense | - | -502.00 | -94.07 Thousand | -32.49 Thousand | -76.06 Thousand | -3.47 Million |
| Earnings before Tax | -7 Million | -12.73 Million | -19.51 Million | -10.89 Million | -8.59 Million | -11.63 Million |
| Net Income | -7 Million | -12.73 Million | -19.42 Million | -10.86 Million | -8.59 Million | -11.63 Million |
| Earnings Per Share Basic | -5.44 | -11.98 | -26.12 | -21.79 | -21.80 | -61.10 |
| Earnings Per Share Diluted | -5.44 | -11.98 | -26.12 | -21.79 | -21.80 | -61.10 |
| Weighted Average Shares Outstanding | 1.42 Million | 1.06 Million | 743.54 Thousand | 498.52 Thousand | 394.09 Thousand | 190.37 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.42 Million | 1.06 Million | 743.54 Thousand | 498.52 Thousand | 394.09 Thousand | 190.37 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -7 Million | -13.31 Million | -19.46 Million | -10.92 Million | -8.14 Million | -6.97 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 32.24 Thousand | - | - | - |
| Cost of Revenue | 141.00 | 141.00 | 141.00 | 564.00 | 141.00 | 141.00 |
| Gross Profit | -141.00 | -141.00 | 32.1 Thousand | -564.00 | -141.00 | -141.00 |
| Operating Expenses | 2.28 Million | 1.84 Million | 1.78 Million | 6.88 Million | 1.35 Million | 1.47 Million |
| Selling, General and Administrative Expenses | 1.27 Million | 1.39 Million | 1.51 Million | - | 1.15 Million | 1.04 Million |
| Research and Development Expenses | 1.01 Million | 454.27 Thousand | 264.43 Thousand | - | 207.12 Thousand | 429.89 Thousand |
| Other Expenses | - | -42.00 | 51.9 Thousand | - | - | -51.9 Thousand |
| Cost and Expenses | 2.28 Million | 1.84 Million | 1.78 Million | 6.88 Million | 1.35 Million | 1.47 Million |
| Operating Income | -2.28 Million | -1.84 Million | -1.78 Million | -6.88 Million | -1.35 Million | -1.47 Million |
| Interest Expense | - | - | 14.89 Thousand | - | - | - |
| Income Tax Expense | -1.00 | -1.00 | 15.89 Thousand | -1.87 Million | 37.27 Thousand | -2.59 Million |
| Earnings before Tax | -2.45 Million | -6.47 Million | -1.9 Million | -7 Million | -1.34 Million | -1.5 Million |
| Net Income | -2.45 Million | -6.47 Million | -1.92 Million | -7.74 Million | -1.38 Million | 1.08 Million |
| Earnings Per Share Basic | -0.59 | -2.19 | -1.15 | - | -1.18 | -1.39 |
| Earnings Per Share Diluted | -0.59 | -2.19 | -1.15 | - | -1.18 | -1.39 |
| Weighted Average Shares Outstanding | 4.18 Million | 2.95 Million | 1.66 Million | 1.42 Million | 1.17 Million | 1.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.18 Million | 2.95 Million | 1.66 Million | 1.42 Million | 1.17 Million | 1.13 Million |
| Gross Margin | - | - | 1.00 | - | - | - |
| EBIT Margin | - | - | -55.32 | - | - | - |
| Profit Margin | - | - | -59.55 | - | - | - |
| EBITDA | -2.28 Million | -1.84 Million | -1.78 Million | - | -1.35 Million | -1.47 Million |
| Earnings Before Tax Margin | - | - | -55.32 | - | - | - |
2186
2351
5884
COG
NSGCF
LTRE